Search filters

List of works by Jens Wild

Altering an Artificial Gagpolnef Polyprotein and Mode of ENV Co-Administration Affects the Immunogenicity of a Clade C HIV DNA Vaccine

scientific article published on April 11, 2012

Broad antibody mediated cross-neutralization and preclinical immunogenicity of new codon-optimized HIV-1 clade CRF02_AG and G primary isolates

scientific article (publication date: 2011)

DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.

scientific article published in August 1997

DNA-Based Vaccination with Polycistronic Expression Plasmids.

scientific article

Efficiency of a myogenic DNA vaccine is strictly dependent upon cellular localization of HIV-1 Pr55(gag).

scientific article

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

scientific article published on 06 December 2006

Identification of the retinoschisin-binding site on the retinal Na/K-ATPase

scientific article published on 02 May 2019

Impact of codon usage modification on T cell immunogenicity and longevity of HIV-1 gag-specific DNA vaccines

scientific article published on 01 January 2002

Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.

scientific article published in April 2004

Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design

scientific article published on October 14, 2010

Myeloid Cell-Derived HIF-1α Promotes Control of Leishmania major.

scientific article published on 17 October 2016

Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen

scientific article published on 01 April 2000

P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses

article

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses

article

Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid.

scientific article published in February 1998

PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae

scientific article published on 01 December 2001

Retinoschisin is linked to retinal Na/K-ATPase signaling and localization

scientific article published on 14 June 2017

The Hepatitis B Virus e Antigen Cannot Pass the Murine Placenta Efficiently and Does Not Induce CTL Immune Tolerance in H-2bMicein Utero

scientific article published on March 30, 1998

Virus-like particles: a novel tool for the induction and monitoring of both T-helper and cytotoxic T-lymphocyte activity.

scientific article published in January 2004

[Status and current strategies of HIV vaccine development]

scientific article published on 01 June 2003